fostamatinib
Selected indexed studies
- Fostamatinib. (, 2006) [PMID:37603672]
- Fostamatinib. (, 2012) [PMID:31643662]
- Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. (Blood, 2024) [PMID:38843478]
_Worker-drafted node — pending editorial review._
Connections
fostamatinib is a side effect of
Sources
- Fostamatinib. (2006) pubmed
- Fostamatinib. (2012) pubmed
- Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. (2024) pubmed
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials. (2018) pubmed
- Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD). (2024) pubmed
- Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial. (2024) pubmed
- Fostamatinib: A Review in Chronic Immune Thrombocytopenia. (2021) pubmed
- PMID:40554644 (2022) pubmed
- Fostamatinib: First Global Approval. (2018) pubmed
- Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. (2024) pubmed